BGC
BIIB icon

Beutel, Goodman & Co’s Biogen BIIB Stock Holding History

Beutel, Goodman & Co’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10
Closed -$1K – 175
2025
Q1 		$1K Sell
10
-1,746,467
-100% -$250M ﹤0.01% 201
2024
Q4 		$267M Buy
1,746,477
+2,323
+0.1% +$392K 1.45% 35
2024
Q3 		$338M Sell
1,744,154
-3,290
-0.2% -$688K 1.67% 31
2024
Q2 		$405M Buy
1,747,444
+181,659
+12% +$39.5M 2.15% 15
2024
Q1 		$338M Buy
1,565,785
+570,329
+57% +$134M 1.74% 25
2023
Q4 		$258M Sell
995,456
-3,820
-0.4% -$938K 1.37% 37
2023
Q3 		$257M Sell
999,276
-70
-0% -$18.7K 1.52% 29
2023
Q2 		$285M Buy
999,346
+21,620
+2% +$6.44M 1.6% 26
2023
Q1 		$272M Buy
977,726
+22,830
+2% +$6.32M 1.6% 27
2022
Q4 		$264M Sell
954,896
-3,085
-0.3% -$871K 1.6% 24
2022
Q3 		$256M Sell
957,981
-8,205
-0.8% -$1.74M 1.73% 24
2022
Q2 		$197M Buy
966,186
+26,025
+3% +$5.32M 1.22% 34
2022
Q1 		$198M Buy
940,161
+26,625
+3% +$5.79M 1.12% 37
2021
Q4 		$219M Buy
913,536
+363,520
+66% +$93.5M 1.25% 34
2021
Q3 		$156M Buy
550,016
+415,883
+310% +$136M 0.95% 40
2021
Q2 		$46.4M Sell
134,133
-38,399
-22% -$11.6M 0.28% 52
2021
Q1 		$48.3M Buy
+172,532
New +$46.5M 0.3% 53

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Beutel, Goodman & Co's BIIB Position: Q2 2025 in Review

Beutel, Goodman & Co sold out of Biogen (BIIB) in Q2 2025, closing a stake of 10 shares — an estimated $1K sold.

Beutel, Goodman & Co first reported a position in BIIB in Q1 2021 and held it in 17 quarters. The position peaked at $405M in Q2 2024. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • Beutel, Goodman & Co reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • Beutel, Goodman & Co sold 10 Biogen shares in Q2 2025, an estimated $1K.
  • Beutel, Goodman & Co first reported a position in Biogen in Q1 2021 and held it in 17 quarters.
  • Beutel, Goodman & Co's Biogen position peaked at $405M in Q2 2024.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Beutel, Goodman & Co's 13F filing for Q2 2025, filed 13 Aug 2025.